nyse:gkos
|
557279
|
Mar 23rd, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
804.00
|
Open
|
|
Mar 23rd, 2024 02:12AM
|
Mar 23rd, 2024 08:06PM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 22nd, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
804.00
|
Open
|
|
Mar 22nd, 2024 02:08AM
|
Mar 22nd, 2024 07:54PM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 21st, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
804.00
|
Open
|
|
Mar 21st, 2024 06:39PM
|
Mar 21st, 2024 06:39PM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 20th, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
802.00
|
Open
|
|
Mar 20th, 2024 03:31AM
|
Mar 20th, 2024 08:40PM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 19th, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
802.00
|
Open
|
|
Mar 19th, 2024 02:43AM
|
Mar 19th, 2024 07:13PM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 18th, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
802.00
|
Open
|
|
Mar 18th, 2024 01:56AM
|
Mar 18th, 2024 08:26PM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 16th, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
801.00
|
Open
|
|
Mar 16th, 2024 01:21AM
|
Mar 16th, 2024 08:12PM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 15th, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
801.00
|
Open
|
|
Mar 15th, 2024 08:13AM
|
Mar 15th, 2024 10:04AM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 14th, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
801.00
|
Open
|
|
Mar 14th, 2024 02:37AM
|
Mar 14th, 2024 01:26PM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|
nyse:gkos
|
557279
|
Mar 13th, 2024 12:00AM
|
Glaukos Corporation
|
22K
|
797.00
|
Open
|
|
Mar 13th, 2024 12:38AM
|
Mar 13th, 2024 11:55AM
|
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
Open
|
Glaucoma, MIGS, Medical Device, Keratoconus, Corneal Crosslinking, Ophthalmic, Corneal Health, Retina, Medical Device, and Pharmaceuticals
|
Open
|
26600 Aliso Viejo Parkway
|
Aliso Viejo
|
CA
|
US
|
92656
|
|
Glaukos
|
Health Care
|
Health Care Equipment & Services
|